ChristianaCare

All visitors are required to wear masks.

For COVID-19 safety, all visitors to ChristianaCare facilities and services are required to wear masks. This includes visitors who are vaccinated. Please read our visitor guidelines before arrival.

Masks required at outpatient locations; visitors and support persons limited

All visitors at outpatient locations must be masked in alignment with the masking guidelines on our visitation policy page here. Patients at ChristianaCare’s outpatient services are advised to come to their appointments alone unless a support person is absolutely needed. If a support person is needed, such as a parent, guardian or spokesperson, we highly encourage that the support person be vaccinated. Outpatient practices are not requiring vaccination or a negative COVID test for visitors at this time.

All hospital visitors required to be vaccinated or have a negative COVID-19 test.

  • Inpatients in our Christiana, Wilmington and Union hospitals may have one visitor daily between 10 a.m. and 8 p.m. The visitor must be 16 or older.
  • Patients having outpatient surgery may have one support person accompany them. Support persons must be 16 or older.
  • All visitors and surgical support people must show proof of vaccination OR a negative COVID-19 test within the prior 72 hours.

Before visiting, click here for more details about visitation.

Visit coronavirus.delaware.gov or cecilcountyhealth.org for local vaccination and testing sites.

For Health Professionals

HIV/AIDS Research

  • The research division of the HIV Community Program was originally funded in 1989 as a site of the Community Program for Clinical Research on AIDS. The HIV Program was one of the first 17 sites in the nation.
  • The goal of the Community Program for Clinical Research on AIDS is to integrate research protocols into the primary-care setting. Under this grant more than 200 patients participated in research protocols. The successful implementation of a research agenda into primary care led to the Delaware Community Program for Clinical Research on AIDS being chosen as one of five NIAID-funded sites to participate in the civilian expansion of the Walter Reed GP-160 Vaccine Trial.

  • As a result of successful enrollment and retention of patients into these studies, the HIV Community Program broadened its focus to include pharmaceutical studies in 1994. Since that time The HIV Community Program has successfully executed more than 15 clinical protocols. These studies have included Phase II, III, and IV trials, as well as expanded-access protocols.

    The HIV Program’s excellent quality-assurance program and dedicated research staff help to ensure the timely and accurate collection of data. The implementation of research into the primary care setting helps to promote drug adherence and provides “one stop shopping” for the HIV-infected patient.

    Research coordinators prepare and coordinate the regulatory requirements of the protocols. They are available during clinic visits to assist the physicians with implementation of the protocol. In addition, they are also available to provide guidance to in-house staff when a study patient is admitted to the hospital.

  • Information about current research opportunities can be obtained by calling the HIV Community Program Office at 302-255-1300.